Strategic Initiative

Slingshot members are tracking this corporate initiative:

Bio-Rad and Illumina partner to develop the most comprehensive next-generation sequencing (NGS) workflow for single-cell analysis. Launch of the solution expected in late 2016 or early 2017.

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ILMN

100%
BIO

100%

Additional Information

Additional Relevant Details Most scientific studies rely on analysis of bulk tissue samples. These samples are usually composed of multiple cell types with varying functions. Gene expression data is averaged across cells, making it difficult to identify differences between cells and to understand the role of cell variation. Single-cell sequencing addresses those challenges and provides deeper insight into cell function, disease progression and therapeutic response. These data can be important in studies of neurological tissues, for example, which are known to have hundreds of specialized cell types. Using Bio-Rad’s best-in-class droplet partitioning technology and Illumina’s leading NGS technologies, the new solution is optimized to isolate and barcode single cells for downstream sequencing. Data analysis is conducted via BaseSpace, Illumina’s cloud-based genomics computing environment. The solution will be scalable to isolate significantly larger numbers of single cells compared to commercially available solutions today, in just a few minutes at a cost-effective price.
http://www.bio-rad.c...
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Jan 11, 2016
Projected Implementation:
Q1, 2016
Relevance Tracked Until:
Q1, 2017
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Partnership, Ngs, Next-generation Sequencing